Mathieu C Tamby
Overview
Explore the profile of Mathieu C Tamby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dib H, Chafey P, Clary G, Federici C, Le Gall M, Dwyer J, et al.
Proteomics
. 2012 Aug;
12(15-16):2547-55.
PMID: 22903842
Human umbilical vein endothelial cells (HUVEC) are widely used as a source of endothelial cells (EC). However, HUVEC characteristics cannot be extrapolated to other types of EC, particularly microvascular ECs....
2.
Bussone G, Tamby M, Calzas C, Kherbeck N, Sahbatou Y, Sanson C, et al.
Ann Rheum Dis
. 2011 Nov;
71(4):596-605.
PMID: 22084393
Objectives: Pulmonary arterial hypertension (PAH) is characterised by remodelling of pulmonary arteries with enhanced vascular smooth muscle cell (VSMC) contraction, migration and proliferation. The authors investigated the presence of antibodies...
3.
Dib H, Tamby M, Bussone G, Regent A, Berezne A, Lafine C, et al.
Eur Respir J
. 2011 Oct;
39(6):1405-14.
PMID: 22005913
Anti-endothelial cell antibodies (AECAs) have been identified in patients with systemic sclerosis (SSc) with and without pulmonary arterial hypertension (PAH) and in patients with idiopathic pulmonary arterial hypertension (iPAH). However,...
4.
Regent A, Dib H, Ly K, Agard C, Tamby M, Tamas N, et al.
Arthritis Res Ther
. 2011 Jun;
13(3):R107.
PMID: 21711540
Introduction: Immunological studies of giant cell arteritis (GCA) suggest that a triggering antigen of unknown nature could generate a specific immune response. We thus decided to detect autoantibodies directed against...
5.
Bussone G, Dib H, Tamby M, Broussard C, Federici C, Woimant G, et al.
Arthritis Res Ther
. 2011 May;
13(3):R74.
PMID: 21569507
Introduction: Antinuclear antibodies (ANAs), usually detected by indirect immunofluorescence on HEp-2 cells, are identified in 90% of patients with systemic sclerosis (SSc). Thus, approximately 10% of SSc patients have no...
6.
Kherbeck N, Tamby M, Bussone G, Dib H, Perros F, Humbert M, et al.
Clin Rev Allergy Immunol
. 2011 Mar;
44(1):31-8.
PMID: 21394427
Pulmonary arterial hypertension is characterized by a remodeling of pulmonary arteries with endothelial cell, fibroblast, and vascular smooth muscle cell activation and proliferation. Since pulmonary arterial hypertension occurs frequently in...
7.
Wang M, Ihida-Stansbury K, Kothapalli D, Tamby M, Yu Z, Chen L, et al.
Circulation
. 2011 Feb;
123(6):631-9.
PMID: 21282500
Background: Microsomal (m) prostaglandin (PG) E₂ synthase (S)-1 catalyzes the formation of PGE₂ from PGH₂, a cyclooxygenase product that is derived from arachidonic acid. Previous studies in mice suggest that...
8.
Ly K, Regent A, Tamby M, Mouthon L
Autoimmun Rev
. 2010 May;
9(10):635-45.
PMID: 20457278
Giant cell arteritis (GCA) is characterized by intimal hyperplasia and luminal obstruction leading to ischemic manifestations involving extra-cranial branches of carotid arteries and aorta. Histopathological lesions involve all layers of...
9.
Tamby M, Servettaz A, Tamas N, Reinbolt J, Caux F, Meyer O, et al.
Biologics
. 2009 Aug;
2(3):583-91.
PMID: 19707389
By using a semi-quantitative immunoblotting technique, we have analyzed serum immunoglobulin G (IgG) reactivities of patients with limited cutaneous systemic sclerosis and anticentromere antibodies, patients with diffuse systemic sclerosis and...
10.
Terrier B, Tamby M, Camoin L, Guilpain P, Broussard C, Bussone G, et al.
Am J Respir Crit Care Med
. 2008 Feb;
177(10):1128-34.
PMID: 18276943
Rationale: Pulmonary arterial hypertension (PAH) may be classified as idiopathic (IPAH) or familial (FPAH) or associated with various conditions and exposures such as dexfenfluramine intake (Dex-PAH) or systemic sclerosis (SSc-PAH)....